Activate Now
 
ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

How Good Fats Prevent Heart Disease

Anti-inflammatory "No More Aches and Pains" Smoothie Bowl

The Bees' Best-Kept Secret: The Amazing Health Benefits of Propolis

Acupuncture: Why It Works

For women, healthy diets may help with mobility when aging

The Relationship Between Vitamin D and Insulin Resistance

8 Things to Consider for Depression

VIDEO: Living with Chronic Pain

ACTION ALERT: Improve US chronic pain care

Supplements Proven Beneficial for Depression

 
Print Page
Email Article

Watch FDA's public review of Ampligen for ME/CFS, online Dec 20

  [ 8 votes ]   [ 1 Comment ]
www.ProHealth.com • December 7, 2012


Midnight Dec 6 was the deadline for patient submission of comments to be considered in the FDA's Dec 20 public review of Ampligen for potential approval as an Rx treatment for ME/CFS.

Now, patients & advocates are invited to view the live webcast of this public review on Dec 20, 8 am to 5 pm Eastern time. Oral testimony is scheduled for approximately 1 pm to 2:30 pm Eastern time.

The FDA has indicated it will post details, including the web address for the webcast and background material for the meeting, sometime on Dec 18 at this FDA site: http://www.fda.gov/AdvisoryCommittees/Calendar/ucm324972.htm.

The FDA also plans to post the webcast in its archive for later viewing.




Post a Comment

Featured Products From the ProHealth Store
Vitamin D3 Extreme™ FibroSleep™ Ultra ATP+, Double Strength

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments Post a Comment

Testinonies for FDA meeting
Posted by: pokeydna
Dec 8, 2012
Patients wanting to send in their comments or testimony can send it to me Bob Miller
At 511bobmiller42@gmail.com and I will present it along with my testimony at the FDA meeting on December 20th. As always we appreciate the support from ProHealth
to the ME/CFS community.

Thank you Rick Carson,

Bob Miller
Reply Reply
 
Natural Pain Relief Supplements

Featured Products

Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%

Natural Remedies

The Curcumin Revolution: 'Golden' Ticket to Better Health The Curcumin Revolution: 'Golden' Ticket to Better Health
Priming Your Immune System for Cold & Flu Season Priming Your Immune System for Cold & Flu Season
Looking for Energy? Turn to Plants. Looking for Energy? Turn to Plants.
Pioneer Scientists Uncover a Revolutionary Neuroprotective Supplement for Nerve Health Pioneer Scientists Uncover a Revolutionary Neuroprotective Supplement for Nerve Health
Safely Burn Away Body Fat Safely Burn Away Body Fat

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE AND SAVE 15% NOW*
Be the first to know about new products, special discounts and the latest health news. *New subscribers only

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map